Phase 1 Influenza A Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

Respiratory Syncytial Virus (RSV)Influenza A(H5N1)

Sanofi570 enrolled6 locationsNCT07516418

Recruiting

Phase 1Phase 2

Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Avian Influenza A Virus

Butantan Institute700 enrolled5 locationsNCT06842173